Importantly, the trispecific TCE retained binding activity for all three antigens and was capable of recruiting T-cells to HER2 and/or HER3-expressing cancer cells and mediating effective cancer cell killing, as shown in 2D and 3D model systems. The gene discussed is ERBB3; the disease is cancer.